Ulcerative colitis (UC) is a condition where the inside of the large intestine gets swollen and causes symptoms like diarrhea and belly pain. This study is checking if a new medicine, SPH3127, is safe and works well for treating people with mild-to-moderate UC. The study will last for 8 weeks, and you might get the medicine or a fake pill called a placebo. If you choose to continue, you could take the real medicine for an extra 10 months.
The study is double-blind, which means neither you nor the doctors will know if you are getting the real medicine or placebo. Pharmacokinetics looks at how the medicine moves through your body. If you have mild-to-moderate UC, are between 18 and 70 years old, and meet other criteria, you might be eligible.
- Study lasts 8 weeks, with a possible 10-month extension.
- Participation involves taking 2 tablets daily.
- You will need to pass certain health checks to join.
How understandable was the trial content above?
Hard to understand
Easy to understand